The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 35533/0013.
Tolterodine tartrate 1mg and 2mg film-coated tablets
Tolterodine tartrate 1mg film-coated tablets
Tolterodine tartrate 2mg film-coated tablets
1. What Tolterodine tartrate is and what it is used for
2. What you need to know before you take Tolterodine tartrate
3. How to take Tolterodine tartrate
4. Possible side effects
5. How to store Tolterodine tartrate
6. Contents of the pack and other information
Tolterodine belongs to a class of medicinal products called antimuscarinics.
Tolterodine tartrate is used for the treatment of the symptoms of overactive bladder syndrome. If you have overactive bladder syndrome you may find that you are unable to control urination, that you need to rush to the toilet with no advance warning and/or go to the toilet frequently.
Talk to your doctor or pharmacist before taking Tolterodine Tartrate.
Ask your doctor or pharmacist before starting treatment with Tolterodine tartrate if you think any of these might apply to you.
Please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription.
Tolterodine, the active substance of Tolterodine tartrate may interact with other medicinal products.
It is not recommended to use tolterodine in combination with:
If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not use Tolterodine tartrate when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant.
It is not known if tolterodine is excreted in the mother’s breast milk. Breast-feeding is not recommended while taking this medicine.
Tolterodine tartrate may make you feel dizzy, tired or affect your sight. Your ability to drive or operate machinery may be affected.
If you have been told that you have an intolerance to some sugars speak to your doctor before taking Tolterodine tartrate.
This medicine contains less than 1mmol sodium (23mg) per 1mg and 2mg film-coated tablets, that is to say essentially “sodium-free”.
Always take Tolterodine tartrate exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The recommended dose is 2mg twice daily. If you have liver or kidney problems, your doctor may reduce your dose to one 1mg tablet twice daily.
Tolterodine tartrate is not recommended for children.
The tablets are for oral use and should be swallowed whole.
Tolterodine tartrate can be taken before, after or during a meal.
If you or somebody else takes too many tablets, contact your doctor or pharmacist immediately.
Symptoms in case of overdose include convulsions, hallucinations, excitation, a heartbeat faster than usual, dilation of the pupil and inability to urinate or breathe normally.
If you forget to take a dose at the usual time, take it as soon as you remember unless it is almost time for your next dose. In that case, omit the forgotten dose and follow the normal dose schedule.
Do not take a double dose to make up for the forgotten dose.
Your doctor will tell you how long your treatment with Tolterodine tartrate will last. Do not stop treatment early because you do not see an immediate effect. Your bladder will need some time to adapt. Finish the course of tablets prescribed by your doctor. If you have not noticed any effect by then, talk to your doctor.
The benefit of the treatment should be re-evaluated after 2 or 3 months.
Always consult your doctor if you are thinking of stopping the treatment.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects although not everybody gets them.
You should see your doctor immediately or go to the casualty department if you experience symptoms of angioedema (allergic reaction), such as:
This occurs uncommonly (occurs in less than 1 in 100 patients).
You should also seek medical attention if you experience a hypersensitivity reaction (for example itching, rash, hives, difficulty breathing). This occurs uncommonly (occurs in less than 1 in 100 patients).
Tell your doctor immediately or go to the casualty department if you notice any of the following:
These may be symptoms of heart failure. This occurs uncommonly (occurs in less than 1 in 100 patients).
The following side effects have been observed during treatment with Tolterodine tartrate with the following frequencies.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Additional reactions reported include severe allergic reactions, confusion, hallucinations, flushed skin, angioedema and disorientation. There have also been reports of worsening symptoms of dementia in patients being treated for dementia.
If you get any of the side effects, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label/carton. The expiry date refers to the last day of that month.
No special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is Tolterodine L-tartrate.
Each 1mg film-coated tablet contains 1mg tolterodine L-tartrate (equivalent to 0.68mg of tolterodine).
Each 2mg film-coated tablet contains 2mg tolterodine L-tartrate (equivalent to 1.37mg of tolterodine).
The other ingredients are:
Core: Microcrystalline cellulose, dibasic calcium phosphate dihydrate, sodium starch glycolate, silica colloidal anhydrous, magnesium stearate.
Film-coating: Hypromellose, lactose monohydrate, polyethylene glycol, titanium dioxide (E171).
Tolterodine tartrate 1mg film-coated tablets are white, round biconvex film-coated tablets, embossed with “1” on one side. Tolterodine tartrate 2mg film-coated tablets are white, round biconvex film-coated tablets, embossed with “2” on one side and with a score line on the other side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
PVC/PE/PVDC Aluminium blister:
Pack sizes of 14, 20, 28, 30, 50, 56, 60 and 100 film-coated tablets.
HDPE tablet container with a child-resistant PP screw cap:
Pack sizes of 60 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
This leaflet was last revised: